You are currently viewing a new version of our website. To view the old version click .

Journal of Personalized Medicine, Volume 10, Issue 3

September 2020 - 86 articles

Cover Story: Unplanned hospital readmissions represent a significant cost in health care. A significant percentage of readmissions could be prevented if inpatient teams were better able to predict patients at high risk of readmission. We report on the implementation of the Epic electronic health record “Unplanned readmission model version 1” and its monitoring over 2 years. This model’s predictive capability to discern high-risk discharges was reflected in the AUC/C-statistics for our three hospitals of 0.716–0.760 for all patients and 0.676–0.695 for general medicine patients. We also present our monitoring methods for the model as well as readmission reduction strategies triggered by the model. View this paper.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (86)

  • Article
  • Open Access
3 Citations
3,441 Views
23 Pages

22 September 2020

In order to provide targeted support to families who are raising children with developmental disorders, it is important to study the family needs and to understand circumstances that may affect them. The aim of this study was to identify the needs of...

  • Article
  • Open Access
15 Citations
4,997 Views
11 Pages

A Data-Driven Approach to Carrier Screening for Common Recessive Diseases

  • Anna V. Kiseleva,
  • Marina V. Klimushina,
  • Evgeniia A. Sotnikova,
  • Mikhail G. Divashuk,
  • Alexandra I. Ershova,
  • Olga P. Skirko,
  • Olga V. Kurilova,
  • Anastasia A. Zharikova,
  • Eleonora Yu. Khlebus and
  • Irina A. Efimova
  • + 5 authors

22 September 2020

Genetic screening is an advanced tool for reducing recessive disease burden. Nowadays, it is still unclear as to the number of genes or their variants that are necessary for effective screening. This paper describes the development of a carrier scree...

  • Article
  • Open Access
3 Citations
4,009 Views
11 Pages

Retrospective CT/MRI Texture Analysis of Rapidly Progressive Hepatocellular Carcinoma

  • Charissa Kim,
  • Natasha Cigarroa,
  • Venkateswar Surabhi,
  • Balaji Ganeshan and
  • Anil K. Pillai

21 September 2020

Rapidly progressive hepatocellular carcinoma (RPHCC) is a subset of hepatocellular carcinoma that demonstrates accelerated growth, and the radiographic features of RPHCC versus non-RPHCC have not been determined. The purpose of this retrospective stu...

  • Article
  • Open Access
9 Citations
5,905 Views
21 Pages

Comprehensive Custom NGS Panel Validation for the Improvement of the Stratification of B-Acute Lymphoblastic Leukemia Patients

  • Adrián Montaño,
  • Jesús Hernández-Sánchez,
  • Maribel Forero-Castro,
  • María Matorra-Miguel,
  • Eva Lumbreras,
  • Cristina Miguel,
  • Sandra Santos,
  • Valentina Ramírez-Maldonado,
  • José Luís Fuster and
  • Natalia de Las Heras
  • + 11 authors

21 September 2020

Background: B-acute lymphoblastic leukemia (B-ALL) is a hematological neoplasm of the stem lymphoid cell of the B lineage, characterized by the presence of genetic alterations closely related to the course of the disease. The number of alterations id...

  • Commentary
  • Open Access
29 Citations
6,687 Views
12 Pages

Biomarkers for Alzheimer’s Disease (AD) and the Application of Precision Medicine

  • Walter J. Lukiw,
  • Andrea Vergallo,
  • Simone Lista,
  • Harald Hampel and
  • Yuhai Zhao

21 September 2020

An accurate diagnosis of Alzheimer’s disease (AD) currently stands as one of the most difficult and challenging in all of clinical neurology. AD is typically diagnosed using an integrated knowledge and assessment of multiple biomarkers and inte...

  • Article
  • Open Access
7 Citations
7,033 Views
25 Pages

Is Structured Exercise Performed with Supplemental Oxygen a Promising Method of Personalized Medicine in the Therapy of Chronic Diseases?

  • Nils Freitag,
  • Kenji Doma,
  • Daniel Neunhaeuserer,
  • Sulin Cheng,
  • Wilhelm Bloch and
  • Moritz Schumann

19 September 2020

Aim: This systematic review aimed to explore the literature to identify in which types of chronic diseases exercise with supplemental oxygen has previously been utilized and whether this type of personalized therapy leads to superior effects in physi...

  • Article
  • Open Access
15 Citations
4,178 Views
14 Pages

An Exploratory Association Analysis of ABCB1 rs1045642 and ABCB1 rs4148738 with Non-Major Bleeding Risk in Atrial Fibrillation Patients Treated with Dabigatran or Apixaban

  • Adela-Nicoleta Roşian,
  • Mihaela Iancu,
  • Adrian Pavel Trifa,
  • Ştefan Horia Roşian,
  • Cristina Mada,
  • Cornelia Paula Gocan,
  • Teodora Niţă,
  • Sabina Istratoaie,
  • Paul-Mihai Boarescu and
  • Anca Dana Buzoianu

18 September 2020

(1) Background: The approach of bleeding complications in patients treated with non-vitamin K oral anticoagulants (NOACs) represents an important issue in clinical practice. Both dabigatran and apixaban are substrates for P-glycoprotein and, therefor...

  • Article
  • Open Access
27 Citations
4,435 Views
12 Pages

18 September 2020

(1) Background: Genomics and pharmacogenomics are relatively new fields in medicine in the United Arab Emirates (UAE). Understanding the knowledge, attitudes and current practices among pharmacists is an important pillar to establish the roadmap for...

  • Article
  • Open Access
8 Citations
3,294 Views
14 Pages

17 September 2020

Cancer stem cells (CSCs) contribute to chemoresistance and tumor relapse. By using the distinct metabolic phenotype of CSC, we designed novel PET parameters for CSC metabolism and investigated their clinical values. Patients with breast cancer who un...

  • Editorial
  • Open Access
4 Citations
4,017 Views
3 Pages

16 September 2020

With the development of novel targeted therapies, including exon skipping/inclusion and gene replacement therapy, the field of neuromuscular diseases has drastically changed in the last several years. Until 2016, there had been no FDA-approved drugs...

of 9

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
J. Pers. Med. - ISSN 2075-4426